ACADIA Pharmaceuticals Inc. (ACAD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
21.15-0.05 (-0.24%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 21.28 |
| Open | 21.34 |
| Bid | 21.00 x 900 |
| Ask | 21.20 x 800 |
| Day's Range | 21.03 - 21.57 |
| 52 Week Range | 21.03 - 58.72 |
| Volume | 4,781,028 |
| Avg. Volume | 1,927,905 |
| Market Cap | 3.385B |
| Beta (5Y Monthly) | 0.82 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.79 |
| Earnings Date | May 05, 2021 - May 10, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 29.44 |
- ACCESSWIRE
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact Its Attorneys, Firm Investigating ACAD for Possible Securities Law Violations
SAN FRANCISCO, CA / ACCESSWIRE / April 16, 2021 / Hagens Berman invites Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) investors with significant losses to submit your losses now.
- ACCESSWIRE
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Acadia Pharmaceuticals Inc. (ACAD) and Encourages Long-Term ACAD Stockholders to Contact the Firm
PHILADELPHIA, PA / ACCESSWIRE / April 15, 2021 / Kaskela Law LLC announces that it is investigating Acadia Pharmaceuticals Inc. ("Acadia" or the "Company") (NASDAQ:ACAD) on behalf of the Company's stockholders.
- ACCESSWIRE
SHAREHOLDER ALERT: Acadia Pharmaceuticals Inc. (ACAD) Investigated for Possible Securities Laws Violations by Labaton Sucharow; Investors Should Contact the Firm
NEW YORK, NY / ACCESSWIRE / April 14, 2021 / Labaton Sucharow LLP a national securities litigation firm, announces that it is investigating Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) for potential violations of the federal securities laws.
© 2021 Verizon Media. All rights reserved.
